Combo Products Typically Would Require Only One User Fee Payment – FDA
This article was originally published in The Gray Sheet
Executive Summary
FDA is proposing to levy two user fees from a combination product sponsor if separate marketing applications are filed, though one of the fees would be waived under certain circumstances
You may also be interested in...
Final Combo Product Dispute Resolution Guidelines Largely Unchanged
FDA's final guidance on formal dispute resolutions for combination products provides additional details on when it is appropriate to file a complaint regarding the review time for a combo product submission
Final Combo Product Dispute Resolution Guidelines Largely Unchanged
FDA's final guidance on formal dispute resolutions for combination products provides additional details on when it is appropriate to file a complaint regarding the review time for a combo product submission
Combo Products User Fees: Industry Comments On FDA Guidance, Eyes Future
Legislating separate user fees for combination products could be debated when device or drug user fee programs come up for reauthorization